|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenues | |||||
| Cost of revenues | |||||
| Gross profit | |||||
| Operating expenses: | |||||
| Selling and marketing | |||||
| General and administrative | |||||
| Research and development | |||||
| Vendor liability forgiveness, net of asset transfers | |||||
| Total operating expenses | |||||
| Operating income (loss) | |||||
| Other income (expense): | |||||
| Interest income | |||||
| Interest income (expense), net | |||||
| Foreign currency exchange loss | |||||
| Other, net | |||||
| Total other income (expense) | |||||
| Income (loss) before income taxes | |||||
| Effective tax rate, amount | |||||
| Net income (loss) | |||||
| Allocation to participating preferred stock | |||||
| Net Income (loss) attributable to common stockholders | |||||
| Basic earnings (loss) per common share | |||||
| Diluted earnings (loss) per common share | |||||
| Basic | |||||
| Diluted | |||||
| Foreign currency translation adjustment | |||||
| Total comprehensive income (loss) | |||||
Loading...